ZOLL Medical to participate in conference to discuss LifeVest wearable defibrillator business

NewsGuard 100/100 Score
Dec 5 2009

ZOLL Medical Corporation (NasdaqGS: ZOLL) announced today that it will participate in a conference call hosted by SunTrust Robinson Humphrey on Thursday, December 10, 2009 at 10:30am EST to discuss the LifeVest® wearable defibrillator business. The call will be hosted by Jonathan Block, Analyst from SunTrust Robinson Humphrey, and will include presentations by ZOLL management and one or more physicians currently knowledgeable about the LifeVest product.

Richard A. Packer, Chairman and Chief Executive Officer of ZOLL, commented, “We are very pleased that Jonathan Block has offered to host this call to discuss a very exciting growth engine for ZOLL. We believe this call will provide investors with a significant opportunity to gain additional insight, from multiple perspectives, into what we believe is a very large market opportunity for ZOLL.”

http://www.zoll.com/


Posted in: Device / Technology News

Tags: ,

Comments (0)

Suggested Reading

With its two doctors planning to retire, an Alabama town patches together health care options
CRT-D upgrade reduces morbidity and mortality in HFrEF patients with RV pacing
Gender differences explored: Cardiovascular health variances in women's lifespan
Preventive ventricular tachycardia ablation cuts down ICD shocks and hospitalizations
Heart Foundation-funded research aims to better treat life-threatening arrhythmias
Bystander defibrillation improves 30-day survival even with short ambulance response times
PROFID EHRA trial aims to personalize the prevention of sudden cardiac death after myocardial infarction
New cryoablation technique eliminates ventricular tachycardia in 94% of patients

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Black patients with ICDs have higher rate of post-implant cardiac events and risk of death